sermorelin / ipamorelin Sermorelin vs Ipamorelin: Differences, Benefits,

c-MET upregulation can be found in the majority of head and neck squamous cell carcinomas

In recent years, due to improvements in living standards and increased awareness of cancer prevention and control, the incidence and mortality rates of EC in China have shown a declining trend from 2000 to 2016, with the average annual percent changes of 4.3% (95% CI = 4.7 to 3.9%) and 3.8% (95% CI = 6.0 to 1.4%), respectively

Children presenting neurological signs or symptoms, those unable to take oral medication, individuals with known malabsorption syndromes, infants under 6 months old, and patients using medications that may interfere with vitamin B12 absorption are typically treated with a parenteral protocol (1)

Cagrilintide and the combination drug CagriSema are investigational treatments currently undergoing regulatory review